FENOFIBRATE 160/200mg CAPSULE

Product description

UNIQUE SELLING POINT 
  • Fenofibrate reduces LDL  concentration in plasma. Also reduces coronory artery  disease risk.
  • Fenofibrate activates peroxisome proliferator activated receptor type alpha (PPARa) that increases the lipolysis and elimination of  atherogenic particles. 

Read more

Specifications

Details Strenght:50.25mg/0.5mg/1mg/2mg
Categories Pharmaceutical PackagingBlister Packaging
Sales markets Middle East Region (e.g. UAE); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from India
Measured In mg
Selling Points International Approvals/Standards

More products from Athena

View all our products (14)
FENOFIBRATE 160/200mg CAPSULE

Contact information

Address

Telephone

Website

View all contact information
Spring-free simplicity for higher volumes: the new UniSafe®️ safety device for 2.25mL prefilled syringes

Spring-free simplicity for higher volumes: the new UniSafe®️ s...

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO ANALYTICAL DEVELOPMENT

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO A...

Tjoapack

Tjoapack

Jiudian Pharmaceutical welcome your communication!

Jiudian Pharmaceutical welcome your communication!

Marchesini Group, Packaging Solutions

Marchesini Group, Packaging Solutions